DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in NTRA — Natera, Inc.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,246,803
-$2,038,932 QoQ
Shares Held
56,168
-35.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#170
of 844 holders
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $1,564,775,803 across 9 Diagnostics & Research names. NTRA ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,757,752 | $1,382,626,541 | |
| 2 | QGEN |
Qiagen N.V.
|
1,971,246 | $77,075,717 | |
| 3 | DHR |
Danaher Corp /De/
|
169,249 | $32,238,546 | |
| 4 | A |
Agilent Technologies, Inc.
|
190,281 | $25,275,024 | |
| 5 | NTRA |
Natera, Inc.
This page
|
56,168 | $15,246,803 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
66,773 | $12,901,879 | |
| 7 | ILMN |
Illumina, Inc.
|
57,762 | $10,156,292 | |
| 8 | WAT |
Waters Corp /De/
|
24,078 | $9,030,213 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,246,803 | 56,168 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,285,735 | 86,433 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,944,619 | 78,330 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,934,794 | 111,417 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $16,644,982 | 98,526 | Shares | Defined | 2025-08-14 | |
| 2021-12-31 | $1,731,824 | 18,544 | Shares | Defined | 2026-05-04 | |
| 2021-09-30 | $564,666 | 5,067 | Shares | Defined | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||